Many patients over the age of 80 can safely and effectively be treated for acute myeloid leukaemia (AML) with venetoclax combined with a hypomethylating agent (VEN-HMA), according to a major new study.
US researchers studied the care of patients i...
1 year ago
The drug Voxelotor is to be available on the NHS, helping up to 4,000 patients in England with sickle cell disease, it has been announced.
The drug is administered once a day as a tablet and earlier in May gained approval from the National Institu...
1 year ago
